{"id":251054,"date":"2018-08-07T12:42:02","date_gmt":"2018-08-07T12:42:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=251054"},"modified":"2018-08-07T12:42:02","modified_gmt":"2018-08-07T12:42:02","slug":"growth-in-the-geriatric-population-upswings-the-global-nonopioid-pain-treatment-market-at-a-cagr-of-1662-by-2026","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/growth-in-the-geriatric-population-upswings-the-global-nonopioid-pain-treatment-market-at-a-cagr-of-1662-by-2026_251054.html","title":{"rendered":"Growth in the Geriatric Population Upswings the Global Non-opioid Pain Treatment Market at a CAGR of 16.62% by 2026"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/08\/1533626697.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/08\/1533626697.jpeg\" alt=\"\" width=\"225\" height=\"\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Global Non-Opioid Pain Treatment Market was valued around $ 7300 million in 2017 and is anticipated to reach $ 29100 million by 2026, growing at an estimated CAGR of 16.62%, during the forecast period 2018-2026.&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">According to a new market research report launched by Inkwood Research, The Global Non-Opioid Pain Treatment Market was valued around $ 7300 million in 2017 and is anticipated to reach $ 29100 million by 2026, growing at an estimated CAGR of 16.62%, during the forecast period 2018-2026.<\/div>\n<p style=\"text-align: justify;\">Browse 49 market data Tables and 28 Figures spread over 158 Pages along with in-depth analysis on &ldquo;Non-Opioid Pain Treatment Market by Products (Medical Cannabis, Menthol-containing, Omega 3 Fatty Acid-containing, Botulinum Toxins, Capsaicin-derived) by Therapeutic Application (Orthopaedic\/Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Other Pain) &amp; by Geography&rdquo;.<\/p>\n<p style=\"text-align: justify;\">This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market, by assessing major geographies such as North America, Europe, Asia Pacific, and Rest of World, and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.<\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;Non-Opioid Pain Treatment Market scenario<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">The growing geriatric population, easy and effective medications of non-opioid drugs for cancer treatment, increased prevalence of migraines &amp; promising pipeline are the factors proliferating the growth of the non-opioid pain treatment market across the globe.<\/p>\n<p style=\"text-align: justify;\">The Non-Opioid Pain Treatment Market report provides data tables and includes charts and graphs for visual analysis.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Free Sample Report for Non-Opioid Pain Treatment Market by Products, Therapeutic Application &amp; Geography: <\/strong><a href=\"https:\/\/www.inkwoodresearch.com\/reports\/global-non-opioid-pain-treatment-market-forecast-2018-2026\/#request-free-sample\"><strong>https:\/\/www.inkwoodresearch.com\/reports\/global-non-opioid-pain-treatment-market-forecast-2018-2026\/#request-free-sample<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Market Segmentation<\/strong><\/p>\n<p style=\"text-align: justify;\">On the basis of Products, Non-Opioid Pain Treatment market is segmented into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>MEDICAL CANNABIS<\/li>\n<li>MENTHOL-CONTAINING<\/li>\n<li>OMEGA 3 FATTY ACID-CONTAINING<\/li>\n<li>BOTULINUM TOXINS<\/li>\n<li>CAPSAICIN-DERIVED<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">On the basis of Therapeutic Application, Non-Opioid Pain Treatment market is segmented into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>ORTHOPAEDIC\/MUSCULOSKELETAL PAIN<\/li>\n<li>NEUROPATHIC PAIN<\/li>\n<li>CANCER PAIN<\/li>\n<li>OTHER PAIN<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Report Highlights<\/strong><\/p>\n<p style=\"text-align: justify;\">&#8211; The report provides a detailed analysis of the current and future market trends, to identify the investment opportunities<br \/>&#8211; Market forecasts till 2026, using estimated market values as the base numbers<br \/>&#8211; Key market trends across the business segments, regions and countries<br \/>&#8211; Key developments and strategies observed in the market<br \/>&#8211; Market dynamics such as drivers, restraints, opportunities and other trends<br \/>&#8211; In-depth company profiles of key players and upcoming prominent players<br \/>&#8211; Growth prospects among the emerging nations through 2026<\/p>\n<p style=\"text-align: justify;\"> <strong>Companies Profiled<\/strong><\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ALLERGAN PLC<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; APHRIA<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AURORA CANNABIS ENTERPRISES INC.<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BEDROCAN<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CANOPY GROWTH CORP.<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CARA THERAPEUTICS<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CENTREXION THERAPEUTICS<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CHT MEDICAL<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CRONOS GROUP<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GW PHARMACEUTICALS<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MEDICAL MARIJUANA INC.<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MEDROPHARM GMBH<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TILRAY<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; VANWAY<\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.inkwoodresearch.com\/reports\/antithrombotic-drugs-market\/\"><strong>Antithrombotic drugs market<\/strong><\/a> &#8211; The Global Antithrombotic Drugs market is anticipated to grow at a CAGR of 6.83% during the forecasting years 2018-2026.<\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.inkwoodresearch.com\/reports\/global-immunohistochemistry-market-forecast-2018-2026\/\"><strong>Immunohistochemistry market<\/strong><\/a> &#8211; The Global Immunohistochemistry market is anticipated to grow at a CAGR of 7.93% during the years 2018-2026.<\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.inkwoodresearch.com\/reports\/global-atopic-dermatitis-drugs-market-forecast-2018-2026\/\"><strong>Atopic Dermatitis Drugs market<\/strong><\/a> &#8211; Global Atopic Dermatitis Drugs market is anticipated to grow at a CAGR of 4.66% over the forecast period.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Inkwood Research<br \/><strong>Contact Person:<\/strong> Clive Cooper<br \/><strong>Email:<\/strong> <a href='http:\/\/www.universalpressrelease.com\/?pr=growth-in-the-geriatric-population-upswings-the-global-nonopioid-pain-treatment-market-at-a-cagr-of-1662-by-2026&#038;type=pra'>Send Email<\/a><br \/><strong>Phone:<\/strong> 1 857-302-4704<br \/><strong>Address:<\/strong>169, Harrison Avenue  <br \/><strong>City:<\/strong> Boston<br \/><strong>State:<\/strong> Massachusetts<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.inkwoodresearch.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.inkwoodresearch.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.inkwoodresearch.com\/\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.abnewswire.com\/press_stat.php?pr=growth-in-the-geriatric-population-upswings-the-global-nonopioid-pain-treatment-market-at-a-cagr-of-1662-by-2026\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Global Non-Opioid Pain Treatment Market was valued around $ 7300 million in 2017 and is anticipated to reach $ 29100 million by 2026, growing at an estimated CAGR of 16.62%, during the forecast period 2018-2026.&#8221; According to a new market &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/growth-in-the-geriatric-population-upswings-the-global-nonopioid-pain-treatment-market-at-a-cagr-of-1662-by-2026_251054.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-251054","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/251054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=251054"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/251054\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=251054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=251054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=251054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}